US 12,329,772 B2
Methods and compositions for administration of iron
Mary Jane Helenek, Brookville, NY (US); Marc L. Tokars, Douglassville, NY (US); and Richard P. Lawrence, Calverton, NY (US)
Assigned to American Regent, Inc., Shirley, NY (US)
Filed by American Regent, Inc., Shirley, NY (US)
Filed on Jun. 16, 2022, as Appl. No. 17/842,483.
Application 15/958,930 is a division of application No. 14/683,415, filed on Apr. 10, 2015, granted, now 10,478,450, issued on Nov. 19, 2019.
Application 17/842,483 is a continuation of application No. 16/825,337, filed on Mar. 20, 2020, granted, now 11,364,260.
Application 16/825,337 is a continuation of application No. 16/438,340, filed on Jun. 11, 2019, granted, now 11,478,502.
Application 16/438,340 is a continuation of application No. 16/192,681, filed on Nov. 15, 2018, granted, now 11,406,656.
Application 16/192,681 is a continuation of application No. 15/958,930, filed on Apr. 20, 2018, granted, now 11,433,091.
Application 14/683,415 is a continuation of application No. 13/847,254, filed on Mar. 19, 2013, abandoned.
Application 13/847,254 is a continuation of application No. 12/787,283, filed on May 25, 2010, granted, now 8,431,549, issued on Apr. 30, 2013.
Application 12/787,283 is a continuation of application No. 11/620,986, filed on Jan. 8, 2007, granted, now 7,754,702, issued on Jul. 13, 2010.
Claims priority of provisional application 60/757,119, filed on Jan. 6, 2006.
Prior Publication US 2023/0008240 A1, Jan. 12, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/7135 (2006.01); A61K 31/715 (2006.01); A61K 31/721 (2006.01); C07H 23/00 (2006.01)
CPC A61K 31/7135 (2013.01) [A61K 31/715 (2013.01); A61K 31/721 (2013.01); C07H 23/00 (2013.01)] 40 Claims
 
1. A method of treating iron deficiency or dysfunctional iron metabolism associated with surgery, the method comprising administering to a human having iron deficiency or dysfunctional iron metabolism associated with surgery a pharmaceutical composition comprising an iron carbohydrate complex in a single dosage unit of at least about 0.6 grams of elemental iron, wherein the pharmaceutical composition is administered in about 15 minutes or less.